Abstract
Myasthenia Gravis (MG) is an autoimmune disorder of neuromuscular transmission characterized by the presence of autoantibodies directed against acetylcholine receptor (AChR), which are detected in more than 85 % of patients’ sera (1). The role of the thymus in MG has been strongly suggested by the favorable clinical effects of thymectomy and by the high incidence of thymic abnormalities (15–20 % thymomas and 50 % hyperplastic thymuses) (2).KeywordsDouble Label ExperimentThymic HyperplasiaThymic LymphocyteThymic AbnormalityHigh Proliferative ResponseThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
